These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 2563989

  • 1. Sulfasalazine therapy in inflammatory bowel disease.
    Das KM.
    Gastroenterol Clin North Am; 1989 Mar; 18(1):1-20. PubMed ID: 2563989
    [Abstract] [Full Text] [Related]

  • 2. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA.
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [Abstract] [Full Text] [Related]

  • 3. [Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases].
    Allgayer H, Kruis W.
    Dtsch Med Wochenschr; 1985 Nov 22; 110(47):1827-9. PubMed ID: 2866083
    [No Abstract] [Full Text] [Related]

  • 4. The use of sulfasalazine in the treatment of inflammatory bowel disease.
    Spector R.
    J Iowa Med Soc; 1983 Jun 22; 73(6):230-4. PubMed ID: 6135735
    [No Abstract] [Full Text] [Related]

  • 5. [Progress in inflammatory diseases of the colon (author's transl)].
    Egger G.
    Ther Umsch; 1974 Nov 22; 31(11):804-9. PubMed ID: 4154520
    [No Abstract] [Full Text] [Related]

  • 6. [New developments and trends in the drug therapy of chronic inflammatory bowel diseases].
    Ewe K.
    Verh Dtsch Ges Inn Med; 1988 Nov 22; 94():178-84. PubMed ID: 2905098
    [No Abstract] [Full Text] [Related]

  • 7. [Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects].
    Dölle W, Daiss W.
    Verh Dtsch Ges Inn Med; 1988 Nov 22; 94():184-91. PubMed ID: 2905099
    [No Abstract] [Full Text] [Related]

  • 8. Sulphasalazine in inflammatory bowel disease: recent advances.
    Cooper BT.
    N Z Med J; 1986 Oct 08; 99(811):757-9. PubMed ID: 2877428
    [No Abstract] [Full Text] [Related]

  • 9. [Drug information. Pentasa--new Danish drug].
    Dahlerup J.
    Sygeplejersken; 1988 Jul 13; 88(28):16. PubMed ID: 2902698
    [No Abstract] [Full Text] [Related]

  • 10. Therapy of inflammatory bowel disease, including use of immunosuppressive agents.
    Korelitz BI.
    Clin Gastroenterol; 1980 May 13; 9(2):331-49. PubMed ID: 6104550
    [No Abstract] [Full Text] [Related]

  • 11. Proceedings: Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    Lendrum R, Walker JG, West B, Hill MJ.
    Gut; 1974 Apr 13; 15(4):344. PubMed ID: 4151868
    [No Abstract] [Full Text] [Related]

  • 12. Pancreatitis and pancreatic necrosis during sulfasalazine therapy.
    Faintuch J, Mott CB, Machado MC.
    Int Surg; 1985 Apr 13; 70(3):271-2. PubMed ID: 2872181
    [Abstract] [Full Text] [Related]

  • 13. Sulfasalazine and new analogues.
    Friedman G.
    Am J Gastroenterol; 1986 Feb 13; 81(2):141-4. PubMed ID: 2868653
    [No Abstract] [Full Text] [Related]

  • 14. Inflammatory bowel disease. Part II.
    Hansen R.
    Proc Annu Meet Med Sect Am Counc Life Insur; 1978 Feb 13; ():41-9. PubMed ID: 39296
    [No Abstract] [Full Text] [Related]

  • 15. [Drug treatment of chronic inflammatory diseases of the intestine].
    Modigliani R.
    Schweiz Med Wochenschr; 1988 May 21; 118(20):737. PubMed ID: 2898809
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacotherapy of inflammatory bowel disease.
    Gardner RC.
    J Maine Med Assoc; 1976 Jul 21; 67(7):206-14. PubMed ID: 9461
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH, Munck LK.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar 21; 4(3):160-70. PubMed ID: 17339853
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.